oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes The Effects of on Health-Related Quality of Life Adults with CKD: FLOW trial Oral Semaglutide and Cardiovascular Outcomes

Exendin-4 DPP-4 resistance due to Gly at position 2

administration of luxendin does not fill the entire ventricles, nor is it localised to the ependymal cells lining the ventricles, but rather is limited to distinct structures within the ventriclespresumably parts of the choroid plexus (Figure 2)

Campforts B, Drukker M, van Amelsvoort T, Bak M

Feel and look great

Patients with favorable GLP1R and GIPR variants often tolerate rapid dosing, while others benefit from conservative increases

These include acute pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, diabetic retinopathy, rapid heartbeat, and suicidal behavior or ideation